Keytruda 00006-3026-02
Generic: Pembrolizumab
- Manufacturer
- Merck Sharp & Dohme Llc
- Dosage Form
- Injection, Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- January 15, 2015
- Listing Expires
- December 31, 2027
- Application
- BLA125514
Need to source Keytruda? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Pembrolizumab | 25 mg/mL |
Drug Class
Programmed Death Receptor-1 Blocking Antibody [EPC]Programmed Death Receptor-1 Blocking Antibody [EPC]Programmed Death Receptor-1-directed Antibody Interactions [MoA]
Selected Package
00006-3026-02Selected1 VIAL in 1 CARTON (0006-3026-02) / 4 mL in 1 VIAL (0006-3026-01)
Other packages for this product(1)
2 VIAL in 1 CARTON (0006-3026-04) / 4 mL in 1 VIAL (0006-3026-01)